Prestige Consumer Healthcare (PBH) Fundamental Analysis: Revenue, Earnings & Valuation

8.27 / 10

Outperform

Fundamentals receive an 8.3/10 score, earning an Outperform rating. Cash‑to‑market and asset‑to‑market ratios are strong, while revenue‑to‑market lags. PB‑ROE is weak, but cash flow growth and profit metrics are positive, indicating solid financial health.

Analysis Checks(3/10)

Revenue-MV

Value-0.21

Score0/3

Weight-22.18%

1M Return-6.46%

Net cash flow from operating activities per share (YoY growth rate %)

Value1.68

Score2/3

Weight10.58%

1M Return2.28%

PB-ROE

Value-0.17

Score1/3

Weight-1.67%

1M Return-0.34%

Basic earnings per share (YoY growth rate %)

Value2.61

Score1/3

Weight2.96%

1M Return0.59%

Total profit (YoY growth rate %)

Value2.96

Score1/3

Weight6.76%

1M Return1.41%

Net cash flow from operating activities (YoY growth rate %)

Value1.04

Score1/3

Weight4.55%

1M Return1.00%

Cash-UP

Value-0.15

Score1/3

Weight3.08%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value2.88

Score1/3

Weight3.22%

1M Return0.65%

Asset-MV

Value-0.05

Score3/3

Weight54.40%

1M Return9.13%

Cash-MV

Value-0.33

Score3/3

Weight38.30%

1M Return6.61%

Is PBH undervalued or overvalued?

PBH scores 8.27/10 on fundamentals and holds a Discounted valuation at present. Backed by its 7.44% ROE, 16.90% net margin, 14.63 P/E ratio, 1.49 P/B ratio, and -11.60% earnings growth, these metrics solidify its Outperform investment rating.